Addus Homecare Co. (ADUS) Expected to Post Earnings of $0.44 Per Share

Analysts expect that Addus Homecare Co. (NASDAQ:ADUS) will post earnings of $0.44 per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Addus Homecare’s earnings, with the lowest EPS estimate coming in at $0.43 and the highest estimate coming in at $0.44. Addus Homecare reported earnings of $0.43 per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 2.3%. The firm is scheduled to issue its next quarterly earnings report on Monday, March 5th.

On average, analysts expect that Addus Homecare will report full-year earnings of $1.58 per share for the current financial year, with EPS estimates ranging from $1.57 to $1.60. For the next fiscal year, analysts expect that the company will post earnings of $1.72 per share, with EPS estimates ranging from $1.67 to $1.81. Zacks’ EPS averages are an average based on a survey of sell-side research analysts that follow Addus Homecare.

Addus Homecare (NASDAQ:ADUS) last announced its earnings results on Monday, November 6th. The company reported $0.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.04. Addus Homecare had a return on equity of 10.35% and a net margin of 4.30%. The firm had revenue of $108.60 million for the quarter, compared to analyst estimates of $108.99 million. During the same quarter last year, the firm posted $0.39 EPS. The business’s revenue was up 4.9% on a year-over-year basis.

A number of research analysts have weighed in on the company. BidaskClub upgraded Addus Homecare from a “sell” rating to a “hold” rating in a report on Friday, January 5th. Zacks Investment Research upgraded Addus Homecare from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 9th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. Addus Homecare has a consensus rating of “Hold” and a consensus target price of $41.33.

In other Addus Homecare news, CEO R Dirk Allison sold 749 shares of the firm’s stock in a transaction on Monday, January 22nd. The stock was sold at an average price of $38.85, for a total value of $29,098.65. Following the transaction, the chief executive officer now owns 33,120 shares in the company, valued at approximately $1,286,712. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider W Bradley Bickham sold 822 shares of the firm’s stock in a transaction on Wednesday, January 17th. The stock was sold at an average price of $37.40, for a total value of $30,742.80. Following the completion of the sale, the insider now directly owns 9,178 shares of the company’s stock, valued at $343,257.20. The disclosure for this sale can be found here. Company insiders own 35.80% of the company’s stock.

Several institutional investors and hedge funds have recently modified their holdings of the business. Dimensional Fund Advisors LP increased its stake in shares of Addus Homecare by 2.3% in the 3rd quarter. Dimensional Fund Advisors LP now owns 887,121 shares of the company’s stock worth $31,316,000 after acquiring an additional 19,823 shares during the last quarter. FMR LLC increased its stake in shares of Addus Homecare by 0.4% in the 2nd quarter. FMR LLC now owns 707,448 shares of the company’s stock worth $26,317,000 after acquiring an additional 3,138 shares during the last quarter. Cortina Asset Management LLC increased its stake in shares of Addus Homecare by 12.6% in the 3rd quarter. Cortina Asset Management LLC now owns 609,003 shares of the company’s stock worth $21,498,000 after acquiring an additional 68,010 shares during the last quarter. Vanguard Group Inc. increased its stake in shares of Addus Homecare by 6.6% in the 2nd quarter. Vanguard Group Inc. now owns 339,297 shares of the company’s stock worth $12,622,000 after acquiring an additional 20,858 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its stake in shares of Addus Homecare by 0.9% in the 3rd quarter. Russell Investments Group Ltd. now owns 302,730 shares of the company’s stock worth $10,686,000 after acquiring an additional 2,629 shares during the last quarter. 92.72% of the stock is owned by institutional investors and hedge funds.

Shares of Addus Homecare (NASDAQ ADUS) traded down $0.30 during trading hours on Tuesday, hitting $36.00. The stock had a trading volume of 6,797 shares, compared to its average volume of 24,080. Addus Homecare has a 52-week low of $29.90 and a 52-week high of $40.75. The stock has a market cap of $421.97, a price-to-earnings ratio of 23.56, a price-to-earnings-growth ratio of 1.60 and a beta of 0.17. The company has a quick ratio of 2.68, a current ratio of 2.68 and a debt-to-equity ratio of 0.23.

TRADEMARK VIOLATION WARNING: “Addus Homecare Co. (ADUS) Expected to Post Earnings of $0.44 Per Share” was published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/01/30/addus-homecare-co-adus-expected-to-post-earnings-of-0-44-per-share.html.

About Addus Homecare

Addus HomeCare Corporation is a provider of personal care services, which are provided primarily in the home. The Company’s personal care services include assistance with bathing, grooming, oral care, skincare, assistance with feeding and dressing, medication reminders, meal planning and preparation, housekeeping and transportation services and other activities of daily living.

Get a free copy of the Zacks research report on Addus Homecare (ADUS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply